Project Grant R01AI191361
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $131,076 Project Grant to The Leland Stanford Junior University under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 4, 2025, with a completion date of July 31, 2027. This research project aims to advance functional understanding of genotypic and phenotypic diversity across Salmonella species, focusing on how evolutionary pressures from human hosts and...
- Federal Grant Award Summary The Leland Stanford Junior University received a $160,448 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 15, 2026, with completion targeted for August 31, 2028. The project develops activity-based probes (ABPs) for targeted imaging and treatment of bacterial otitis media (OM), an infection of the middle ear that represents one of the most...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a $192,672 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective September 1, 2025, through August 31, 2030. The award supports biomedical research investigating the role of PF bacteriophage in promoting Pseudomonas aeruginosa (PA) pathogenesis during chronic lung infections in cystic fibrosis patients. The research...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a $423,500 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective July 25, 2025, with completion scheduled for June 30, 2027. This award supports investigator-initiated biomedical research focused on understanding and addressing antibiotic diffusion barriers in cystic fibrosis (CF) patients, specifically...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a Project Grant of $153,512 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on December 13, 2025, with an ultimate completion date of June 30, 2026. This award funds research to characterize the renal immune microenvironment in antibody-mediated rejection (ABMR) using imaging mass cytometry technology. The research aims to develop...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a Project Grant of $150,104 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop a predictive spillover risk model for Japanese Encephalitis Virus (JEV) in the United States. The award, initiated on March 10, 2026, with a completion date of October 31, 2028, funds research addressing a critical gap in understanding JEV...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2.73 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Regents of the University of Colorado-Denver, with an award date of September 4, 2025, and completion date of August 31, 2029. This research project investigates phage-salmonella interactions during oxidative stress, with the primary objective of elucidating the mechanisms by...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a $3,045,291 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, through July 31, 2029. This collaborative research project, led by the Carette, Chiu, and Nagamine laboratories, will conduct fundamental and translational research to elucidate the molecular mechanisms by which the MFSD6 receptor...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $596,318 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 10, 2026 through January 31, 2031. This award supports research aimed at defining virulence factor functions in non-typhoidal Salmonella typhimurium using minimal pathogen genomes. The research employs genetically...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Illinois a Project Grant of $154,052 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 5, 2025, with a completion date of July 31, 2027. This research project investigates the role of arginine as a metabolic cue during enteric infection, specifically examining how arginine availability in the gastrointestinal environment modulates the...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a Project Grant of $771,210 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 19, 2026. The research initiative, titled "Salmonella Persistence in Mesenteric Lymph Nodes," delivers a comprehensive five-year research program extending through January 31, 2031, aimed at elucidating the molecular mechanisms by which Salmonella enterica serovar Typhimurium (STM) maintains persistent infections in mammalian tissues, particularly within mesenteric lymph nodes (MLN). The funded research produces scientific knowledge and experimental findings organized across three primary research aims: (1) characterizing interactions between eosinophils and STM through in vitro and in vivo investigations; (2) mapping immune-pathogen interactions within distinct MLNs using spatial transcriptomics and immune profiling techniques; and (3) defining immunoregulatory functions of eosinophils that influence STM persistence. The research outcomes are intended to identify host pathways amenable to therapeutic and preventive interventions against chronic Salmonella carriage states, with potential applications toward pharmacological eradication strategies for persistent bacterial infections.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $771.2k | 2/19/26 |